BRISTOL MYERS SQUIBB CO | 2013 | FY | 3


The following is summarized financial information for interests in the partnerships with Sanofi for the territory covering Europe and Asia, which are not consolidated but are accounted for using the equity method:
 
 
Year Ended December 31,
Dollars in Millions
 
2013
 
2012
 
2011
Net sales
 
$
395

 
$
1,077

 
$
1,469

Gross profit
 
319

 
453

 
658

Net income
 
$
313

 
$
394

 
$
562


us-gaap:EquityMethodInvestmentsDisclosureTextBlock